Shockwave Medical, Inc. (NASDAQ:SWAV) Given Consensus Rating of “Hold” by Analysts

Shares of Shockwave Medical, Inc. (NASDAQ:SWAVGet Free Report) have been given an average recommendation of “Hold” by the eleven research firms that are currently covering the stock, MarketBeat.com reports. Ten equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $309.11.

A number of research firms have recently commented on SWAV. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $335.00 price target (up previously from $270.00) on shares of Shockwave Medical in a report on Monday, April 8th. Wells Fargo & Company upped their target price on shares of Shockwave Medical from $200.00 to $210.00 and gave the company an “equal weight” rating in a research note on Friday, February 16th. TheStreet upgraded shares of Shockwave Medical from a “c+” rating to a “b” rating in a research note on Thursday, February 15th. Canaccord Genuity Group restated a “hold” rating and issued a $335.00 target price (up previously from $263.00) on shares of Shockwave Medical in a report on Friday, April 5th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Shockwave Medical in a report on Friday, April 5th.

Read Our Latest Research Report on Shockwave Medical

Shockwave Medical Trading Down 0.1 %

Shockwave Medical stock opened at $329.64 on Wednesday. Shockwave Medical has a 12 month low of $157.00 and a 12 month high of $331.58. The company has a market capitalization of $12.37 billion, a price-to-earnings ratio of 77.02, a price-to-earnings-growth ratio of 2.41 and a beta of 0.88. The business’s fifty day simple moving average is $318.79 and its two-hundred day simple moving average is $248.56. The company has a current ratio of 13.81, a quick ratio of 12.61 and a debt-to-equity ratio of 0.97.

Shockwave Medical (NASDAQ:SWAVGet Free Report) last announced its quarterly earnings results on Monday, May 6th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.99 by $0.45. The company had revenue of $218.80 million for the quarter, compared to analysts’ expectations of $207.69 million. Shockwave Medical had a net margin of 20.75% and a return on equity of 24.79%. Shockwave Medical’s revenue was up 35.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.03 EPS. As a group, equities analysts predict that Shockwave Medical will post 5.03 earnings per share for the current fiscal year.

Insider Transactions at Shockwave Medical

In related news, VP Trinh Phung sold 599 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $259.24, for a total transaction of $155,284.76. Following the completion of the transaction, the vice president now directly owns 31,031 shares in the company, valued at approximately $8,044,476.44. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other Shockwave Medical news, VP Trinh Phung sold 599 shares of the firm’s stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $259.24, for a total transaction of $155,284.76. Following the sale, the vice president now directly owns 31,031 shares of the company’s stock, valued at $8,044,476.44. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Isaac Zacharias sold 4,000 shares of the company’s stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $260.36, for a total value of $1,041,440.00. Following the completion of the transaction, the insider now directly owns 61,372 shares of the company’s stock, valued at approximately $15,978,813.92. The disclosure for this sale can be found here. Insiders have sold 12,120 shares of company stock valued at $3,310,021 over the last quarter. 3.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Shockwave Medical

Several hedge funds have recently modified their holdings of the stock. Iron Triangle Partners LP purchased a new position in Shockwave Medical during the 1st quarter valued at approximately $25,964,000. First Light Asset Management LLC boosted its position in shares of Shockwave Medical by 35.0% during the 1st quarter. First Light Asset Management LLC now owns 161,484 shares of the company’s stock valued at $52,584,000 after acquiring an additional 41,861 shares during the last quarter. Brown Capital Management LLC grew its holdings in shares of Shockwave Medical by 2.4% in the first quarter. Brown Capital Management LLC now owns 70,073 shares of the company’s stock valued at $22,818,000 after purchasing an additional 1,674 shares in the last quarter. Advisors Asset Management Inc. grew its holdings in shares of Shockwave Medical by 0.8% in the first quarter. Advisors Asset Management Inc. now owns 5,731 shares of the company’s stock valued at $1,866,000 after purchasing an additional 45 shares in the last quarter. Finally, Shell Asset Management Co. increased its position in Shockwave Medical by 30.6% in the first quarter. Shell Asset Management Co. now owns 1,718 shares of the company’s stock worth $559,000 after purchasing an additional 403 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Shockwave Medical

(Get Free Report

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.

Featured Stories

Analyst Recommendations for Shockwave Medical (NASDAQ:SWAV)

Receive News & Ratings for Shockwave Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shockwave Medical and related companies with MarketBeat.com's FREE daily email newsletter.